Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Venkatraman Radhakrishnan

Showing results (131-140 of 147) with videos related to

Pageof 15
Sort By:
Trials|February 1, 2022
Protocol for ICiCLe-ALL-14 (InPOG-ALL-15-01): a prospective, risk stratified, randomised, multicentre, open label, controlled therapeutic trial for newly diagnosed childhood acute lymphoblastic leukaemia in IndiaNandana Das, Shripad Banavali, Sameer Bakhshi, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|November 20, 2019
Evaluation of Cytogenetic Abnormalities in Patients with Acute Lymphoblastic LeukemiaPavan Reddy, Ramesh Shankar, Teena Koshy, et al.
Pediatric Blood & Cancer|July 22, 2021
Treating early-stage Hodgkin lymphoma in resource-limited settings: InPOG-HL-15-01 experienceAmita Mahajan, Manisha Singh, Sameer Bakhshi, et al.
Indian Journal of Pediatrics|June 23, 2022
Empirical Antitubercular Treatment for Lymphadenopathy: Are We Missing Lymphoma?Amita Mahajan, Sameer Bakhshi, Manisha Singh, et al.
The Lancet Regional Health. Southeast Asia|June 9, 2025
Risk stratified treatment for childhood acute lymphoblastic leukaemia: a multicentre observational study from IndiaManash Pratim Gogoi, Parag Das, Nandana Das, et al.
JCO Global Oncology|July 19, 2022
Cancer Medicines: What Is Essential and Affordable in India?Manju Sengar, Adam Fundytus, Wilma Hopman, et al.
Pediatric Blood & Cancer|July 4, 2025
Patterns of Care and Survival of Wilms Tumor in Children in India: A Retrospective Multicentric INPHOG StudySirisha Rani Siddaiahgari, Sandhya Vaddadi, Varshini Bandi, et al.
BMJ Global Health|October 23, 2025
Mapping of current resources and models of care for paediatric cancer survivors in Asia: a multinational surveyWinnie Wan Yee Tso, Melissa M Hudson, Ramandeep Singh Arora, et al.
Blood Cancer Journal|March 15, 2025
Outcomes and prognostic factors in patients with Burkitt lymphoma/leukemia in adolescents and adults: an experience from hematology cancer consortiumAkhil Rajendra, Manju Sengar, Anu Korula, et al.
Blood Cancer Journal|January 6, 2022
Outcomes of patients with hematologic malignancies and COVID-19 from the Hematologic Cancer Registry of IndiaArihant Jain, Lingaraj Nayak, Uday Prakash Kulkarni, et al.
Pageof 15

Showing results (131-140 of 147) with videos related to

Sort By:
Pageof 15
Trials|February 1, 2022
Protocol for ICiCLe-ALL-14 (InPOG-ALL-15-01): a prospective, risk stratified, randomised, multicentre, open label, controlled therapeutic trial for newly diagnosed childhood acute lymphoblastic leukaemia in IndiaNandana Das, Shripad Banavali, Sameer Bakhshi, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|November 20, 2019
Evaluation of Cytogenetic Abnormalities in Patients with Acute Lymphoblastic LeukemiaPavan Reddy, Ramesh Shankar, Teena Koshy, et al.
Pediatric Blood & Cancer|July 22, 2021
Treating early-stage Hodgkin lymphoma in resource-limited settings: InPOG-HL-15-01 experienceAmita Mahajan, Manisha Singh, Sameer Bakhshi, et al.
Indian Journal of Pediatrics|June 23, 2022
Empirical Antitubercular Treatment for Lymphadenopathy: Are We Missing Lymphoma?Amita Mahajan, Sameer Bakhshi, Manisha Singh, et al.
The Lancet Regional Health. Southeast Asia|June 9, 2025
Risk stratified treatment for childhood acute lymphoblastic leukaemia: a multicentre observational study from IndiaManash Pratim Gogoi, Parag Das, Nandana Das, et al.
JCO Global Oncology|July 19, 2022
Cancer Medicines: What Is Essential and Affordable in India?Manju Sengar, Adam Fundytus, Wilma Hopman, et al.
Pediatric Blood & Cancer|July 4, 2025
Patterns of Care and Survival of Wilms Tumor in Children in India: A Retrospective Multicentric INPHOG StudySirisha Rani Siddaiahgari, Sandhya Vaddadi, Varshini Bandi, et al.
BMJ Global Health|October 23, 2025
Mapping of current resources and models of care for paediatric cancer survivors in Asia: a multinational surveyWinnie Wan Yee Tso, Melissa M Hudson, Ramandeep Singh Arora, et al.
Blood Cancer Journal|March 15, 2025
Outcomes and prognostic factors in patients with Burkitt lymphoma/leukemia in adolescents and adults: an experience from hematology cancer consortiumAkhil Rajendra, Manju Sengar, Anu Korula, et al.
Blood Cancer Journal|January 6, 2022
Outcomes of patients with hematologic malignancies and COVID-19 from the Hematologic Cancer Registry of IndiaArihant Jain, Lingaraj Nayak, Uday Prakash Kulkarni, et al.
Pageof 15